Michelle Dawson posts

Post published on Twitter/X on 14 Feb 2021 03:47

Back to posts Previous post Next post
Twitter/X Clinical trial clinicaltrials.gov Extract quoted in the post External link integrated into the post Autism terms
Open original post

Information about the link integrated into the post

Clinical trial

Jazz Pharmaceuticals (2021). Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder. ClinicalTrials.gov. Jazz Pharmaceuticals.

More information

Structured cited links

1 cited resource

Clinical trial Fetched Post clinicaltrials.gov

Jazz Pharmaceuticals (2021). Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder. ClinicalTrials.gov. Jazz Pharmaceuticals.

Publication date
31 May 2021
Identifier
NCT04745026
Authors
Jazz Pharmaceuticals
Source
ClinicalTrials.gov
Reference type
clinical_trial
Publisher
Jazz Pharmaceuticals
Metadata source
clinicaltrials.gov

Abstract

This study will be conducted to evaluate the efficacy of GWP42003-P, compared with placebo, in reducing symptom severity in children with Autism Spectrum Disorder (ASD).

Open source